Feasibility of Vaginal Progesterone to Reduce HIV-Associated Preterm Birth

NCT02970552 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

PreTerm Birth

Interventions

DRUG: Vaginal Progesterone
DRUG: Placebo

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]